Intuitive said Thursday the Food and Drug Administration has cleared a stapler for use with its single-port robotic surgery system.
The device, which Intuitive said is the first stapler designed for single-port robotic surgery, shares features found in the company’s multi-port products to reduce the risk of tissue damage.

Boston Scientific has issued an urgent recall of some of its Accolade pacemakers following reports of malfunctions that have been tied to two patient deaths.

Abiomed, part of Johnson & Johnson MedTech, recently presented positive results from the first completed pivotal trial on Impella ECP, a novel transvalvular axial flow pump with compressible pump architecture. 

AngioDynamics has teamed up with the University College London Hospital (UCLH) in the UK to launch a prospective registry study evaluating the long-term effects of the NanoKnife system for treating unifocal intermediate-risk prostate cancer.

Funding issues and limited use of unique device identifiers are hurdles to expanding an FDA system to monitor medical device safety, the federal watchdog said.

Thermo Fisher Scientific Inc. has completed its acquisition of Olink Holding AB, a provider of next-generation proteomics solutions. The transaction values Olink at approximately $3.1 billion. Olink will become part of Thermo Fisher's Life Sciences Solutions segment.

Usually, Cordis is the company that is acquired in transactions that reach past the $1 billion threshold. However, the Hialeah, FL-based company is on the other side of the table – announcing it was picking up MedAlliance in a transaction that could be as much as $1.135 billion.

GE HealthCare and Interbrand unveiled the spinoff’s long-awaited brand strategy Monday morning.

The $35 billion unit, which is GE’s first public spinoff and has been trading on the Nasdaq since January 3, has new branding built around “customer needs, patient outcomes and precision care.”